aid: peel-therapeutics
name: Peel Therapeutics
description: >-
  Peel Therapeutics is an evolutionary-medicine biotechnology company headquartered in Salt Lake City,
  Utah, with research teams in the United States and Israel. Co-founded in 2015 by pediatric oncologist
  Dr. Joshua Schiffman, the company translates molecules that evolution has already validated in nature
  into therapeutics for patients with cancer and inflammatory disease. Its founding program is built on
  elephant p53 (EP53) — elephants carry roughly forty copies of the p53 tumor-suppressor gene against the
  human two — delivered as liposomal protein nanoparticles, alongside PEEL-224, a TOP1 inhibitor in
  clinical development. Discovery runs on the company's proprietary, internal Darwin.AI platform and the
  Darwin Biobank, a comparative-oncology sample collection. Peel is a therapeutics developer rather than a
  software vendor: it publishes no developer program, no public API, and no machine-readable API contract.
url: https://raw.githubusercontent.com/api-evangelist/peel-therapeutics/refs/heads/main/apis.yml
deliveryModel:
  model: saas
  open_source: false
  commercial: true
  callable_host: false
  label: Hosted service · you call their endpoint
  confidence: medium
  source:
  - pricing
  generated: '2026-08-28'
  method: derived
image: https://peeltx.com/wp-content/uploads/peel_facebook_card-scaled.jpg
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.20'
created: '2026-08-26'
modified: '2026-08-26'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Life Sciences
- Healthcare
- Oncology
- Drug Discovery
- Clinical Trials
- Research
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/peel-therapeutics-domain-security.yml
- type: Website
  url: https://peeltx.com/
- type: About
  url: https://peeltx.com/about/
- type: Blog
  url: https://peeltx.com/news/
- type: Support
  url: https://peeltx.com/contact/
- type: PrivacyPolicy
  url: https://peeltx.com/privacy-policy/
- type: TermsOfService
  url: https://peeltx.com/site-terms/
- type: LinkedIn
  url: https://www.linkedin.com/company/peel-therapeutics/
- type: LLMsTxt
  url: llms/peel-therapeutics-llms.txt
x-enrichment:
  date: '2026-08-26'
  status: minimal
  artifacts_added: 3
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: >-
    Peel Therapeutics is a clinical-stage drug developer whose product is a therapeutic pipeline
    (EP53 nanoparticles, PEEL-224); peeltx.com is a nine-page WordPress marketing site where every
    developer path — /api, /developers, /docs, /openapi.json, /swagger.json, /graphql — returns the
    theme's 404, the Darwin.AI discovery platform is internal-only and never exposed, and the sole
    machine-readable surface is the CMS's default, unadvertised /wp-json/ endpoint rather than a
    product API.
  evidence:
    - url: https://peeltx.com/openapi.json
      status: 404
    - url: https://peeltx.com/developers
      status: 404
    - url: https://peeltx.com/graphql
      status: 404
    - url: https://peeltx.com/.well-known/api-catalog
      status: 404
    - url: https://peeltx.com/.well-known/agent-card.json
      status: 404
    - url: https://peeltx.com/llms.txt
      status: 200
    - url: https://peeltx.com/
      status: 200
  checked: '2026-08-26'